Dedicated to Research Since 1993

Global Pharmaceutical Contract Manufacturing Market by Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Pharmaceutical Contract Manufacturing Market was valued at USD XX billion in the year 2017. Global Pharmaceutical Contract Manufacturing market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.

Patheon (Netherlands), Catalent (U.S.), Lonza (Switzerland), Boehringer Ingelheim BioXcellence (Germany), Famar S.A. (Greece), are some of the key players in the Global Pharmaceutical Contract Manufacturing market.

In the global Pharmaceutical Contract Manufacturing market by region, North America region holds the highest market share in 2017 and Asia Pacific region is considered as the fastest growing market in the forecasted period. At the country level U.S, Canada, China, and Japan are projected to grow strongly in the coming years.   


Increasing Outsourcing Volume by Big Pharmaceutical Companies


Increasing Lead Time and Logistics Costs


Increasing Investment in R&D

Opportunity in developing market


Stringent Regulatory Requirements

The segmentation is done on the basis of services and by region. On the basis of services type, the global Pharmaceutical Contract Manufacturing market is sub-segmented as Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing and secondary packaging of which the Active Pharmaceutical Ingredient (API) segment is expected to hold the highest market share and is growing with the highest CAGR of XX% during the forecast period.

Key Benefits for Stakeholders

Electrophoresis product manufacturers

Biotechnology and pharmaceutical companies

Government agencies

Contract research organizations

Academic and research institutions

Hospitals and diagnostic centers Regulatory bodies and consumers.

By Service Type

Active Pharmaceutical Ingredient (API) Manufacturing

Finished Dosage Formulation (FDF) Development & Manufacturing

            Solid Dose Formulation

            Liquid Dose Formulation

            Injectable Dose Formulation

Secondary Packaging

By Region

North America




Key Market Players

Catalent Inc.

Recipharm AB

Jubilant Life Sciences Ltd

Patheon Inc.

Boehringer Ingelheim 

Pfizer Centresource



Baxter Biopharma Solutions


 (A brief overview of 10 companies is also provided)

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

    Key Data from Secondary Research

       2.1.2. Primary Research

    Key Data from Primary Research

    Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary


4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Pharmaceutical Contract Manufacturing Market, By Service Type

6.1 Active Pharmaceutical Ingredient (API) Manufacturing

6.2 Finished Dosage Formulation (FDF) Development & Manufacturing

            6.2.1 Solid Dose Formulation

            6.2.2 Liquid Dose Formulation

            6.2.3 Injectable Dose Formulation

6.3 Secondary Packaging

7. Geographical Analysis

7.1. Introduction

7.2. North America

       7.2.1. U.S.

       7.2.2. Canada

       7.2.3. Mexico

7.3. Europe

       7.3.1. U.K.

       7.3.2. Germany

       7.3.3. France

       7.3.4. RoE

7.4. Asia Pacific

       7.4.1. China

       7.4.2. Malaysia

       7.4.3. South Korea

       7.4.4. India

            7.4.5 RoAPAC

7.5. RoW

       7.5.1. Latin America

       7.5.2. Middle East and Africa

8. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

8.1 Catalent Inc.

8.2 Recipharm AB

8.3 Jubilant Life Sciences Ltd

8.4 Patheon Inc.

8.5 Boehringer Ingelheim 

8.6 Pfizer Centresource

8.7 Aenova 

8.8 Famar

8.9 Baxter Biopharma Solutions

8.10 Lonza

(A brief overview of 10 companies is also provided.)

9. Competitive Analysis

9.1. Introduction

9.2. Market Positioning of Key Players

9.3 Competitive Strategies Adopted by Leading Players

        9.3.1. Investments & Expansions

        9.3.2. New Product Launches

        9.3.3. Mergers & Acquisitions

        9.3.4. Agreements, Joint Ventures, and Partnerships

10. Appendix

10.1. Questionnaire

10.2. Available Customizations 

10.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.


No Content Available.



Related Reports

Fatal error: Maximum execution time of 30 seconds exceeded in /home/genesismarketins/public_html/system/libraries/Session/drivers/Session_files_driver.php on line 263